Articles July 2, 2020 Step Up to GMP Manufacturing or Outsource to a CDMO: Considerations and Tips Whether you are developing a new monoclonal antibody (mAb), cell therapy, gene therapy, or... admin-element
Articles March 12, 2020 Getting Ahead of the Game in Cell and Gene Therapy Successes in the clinic have placed many cell and gene therapies on an accelerated route… admin-element
ArticlesDownstream February 13, 2020 Purification of Plasmid DNA Plasmid DNA is the building block of advanced therapies. As these therapies take off, so… admin-element
ArticlesDownstreamUpstream January 30, 2020 Mapping a Route for Cell and Gene Therapy Process Development The regenerative medicine field is still quite young, and companies developing commercial processes... admin-element
ArticlesDownstreamUpstream December 5, 2019 New Therapies Present Scaling Challenges Manufacturing differences between traditional mAb therapies and newer biotherapeutics dictate whether... admin-element
ArticlesDownstreamRegulatoryUpstream July 18, 2019 Design Considerations for a Commercial Cell and Gene Therapy Facility The commercialization of cell and gene therapies has become a reality, prompting deeper... admin-element
Articles October 5, 2017 Patenting Prospects for Cell-Based Therapies Cell-based therapies are moving medical treatments forward, but intellectual property... admin-element
ArticlesDownstreamRegulatoryUpstream April 19, 2017 Downstream Processing for Cell-Based Therapies With increasing numbers of advanced therapies—including cell and gene therapies—entering early- and... admin-element